评估COVID-19疫苗的短期不良事件:一个观察性研究

Fatemeh Fathi1, Ali Ameri1, Omid Safa2

  • 1Student Research Committee, Faculty of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Medicine
|February 23, 2024
PubMed
概括

来自Sputnik V,AstraZeneca和Sinopharm的COVID-19疫苗被评估为短期不良事件 (AE). 阿斯特拉泽内卡的局部和全身AE比Sinopharm更多,疲劳和注射部位疼痛是最常见的. 所有的疫苗都是安全的和可以容忍的.